Pinned straw:
Discl: Held IRL 4.04% and in SM
Fully agree @wonkeydonkey !
The XRF price tends to drift down, then sharply corrects upwards, in nice waves. Because it is fundamentally as sound a company as it gets, it has thus far, not worried me at all.
Just checked the chart. The price fell to the 61.8% retracement 2x in the past month, almost to the dot, and rebounded from that this morning to now be above the long-term 200 Simple Moving Average trend line. I was braced for a fall to ~1.74 which has been a bit of a congestion area. But it has been a very nice healthy correction thus far ...

@wonkeydonkey it could be as a result of a post today on Livewire by Ben Richards, Seneca Financial Solutions as follows:
"XRF Scientific manufactures equipment and chemicals for the scientific, analytical, and mining industries, primarily focused on X-ray fluorescence (XRF) technology and solutions for XRF sample preparation, including fusion equipment and labware.
Richards notes that, “the recent market volatility has led to quality stocks selling off indiscriminately, creating selective opportunities in companies such as XRF.”
“XRF has compounded earnings at 26% p.a. over the last 5 years, versus the ASX200's growth rate of 8% p.a. over the same period. Despite this, XRF trades on a P/E of just 21x.
With a market cap of just $268 million, we see XRF's growing scale as attracting a new pool of investors, including institutional investors that are only now hearing XRF's story for the first time."
"XRF has taken market share from international competitors and now has cyclical tailwinds. Commodity prices are rising (led by gold & copper), explorers are raising capital hand over fist (exploration financings +123% YoY in October per CapIQ), and sample volumes at laboratories are inflecting higher (per ALS result in November) - all positive leading indicators for XRF.”